CN Patent

CN115490705B — N-大环酰胺类化合物、其制备方法及其作为药物的应用

Assigned to Chengdu Where Nokia Biological Medicine Science And Technology Co ltd · Expires 2025-04-01 · 1y expired

What this patent protects

本发明涉及具有结构通式(I)和结构通式(II)所示结构的N‑大环酰胺类化合物或其异构体、非对映体、对映体、前药、药学上可接受的盐，其中L、X、Y、Z、R 1 、A、B、C各自如本申请说明书中所定义。本发明还涉及具有结构通式(I)和结构通式(II)所示结构的N‑大环酰胺类化合物或其异构体、非对映体、对映体、前药、药学上可接受的盐在医药方面的应用，

USPTO Abstract

本发明涉及具有结构通式(I)和结构通式(II)所示结构的N‑大环酰胺类化合物或其异构体、非对映体、对映体、前药、药学上可接受的盐，其中L、X、Y、Z、R 1 、A、B、C各自如本申请说明书中所定义。本发明还涉及具有结构通式(I)和结构通式(II)所示结构的N‑大环酰胺类化合物或其异构体、非对映体、对映体、前药、药学上可接受的盐在医药方面的应用，

Drugs covered by this patent

Patent Metadata

Patent number
CN115490705B
Jurisdiction
CN
Classification
—
Expires
2025-04-01
Drug substance claim
No
Drug product claim
No
Assignee
Chengdu Where Nokia Biological Medicine Science And Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.